Fangda Li

865 total citations · 4 hit papers
20 papers, 566 citations indexed

About

Fangda Li is a scholar working on Pulmonary and Respiratory Medicine, Biotechnology and Immunology. According to data from OpenAlex, Fangda Li has authored 20 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 6 papers in Biotechnology and 6 papers in Immunology. Recurrent topics in Fangda Li's work include Cancer Research and Treatments (5 papers), Aortic aneurysm repair treatments (4 papers) and CAR-T cell therapy research (3 papers). Fangda Li is often cited by papers focused on Cancer Research and Treatments (5 papers), Aortic aneurysm repair treatments (4 papers) and CAR-T cell therapy research (3 papers). Fangda Li collaborates with scholars based in China, United States and Germany. Fangda Li's co-authors include Nicholas Arpaia, Tal Danino, Courtney Coker, Jongwon Im, Rosa L. Vincent, Thomas Savage, Kenia de los Santos-Alexis, Kelly Pu, Jaeseung Hahn and Mathieu Rouanne and has published in prestigious journals such as Nature, Science and Nature Biotechnology.

In The Last Decade

Fangda Li

17 papers receiving 559 citations

Hit Papers

A programmable encapsulation system improves delivery of ... 2022 2026 2023 2024 2022 2023 2023 2024 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fangda Li China 10 291 267 162 119 103 20 566
Jongwon Im United States 6 243 0.8× 233 0.9× 160 1.0× 81 0.7× 73 0.7× 6 471
Starsha Kolodziej United States 6 176 0.6× 146 0.5× 191 1.2× 62 0.5× 99 1.0× 11 549
Rosa L. Vincent United States 7 454 1.6× 371 1.4× 263 1.6× 191 1.6× 138 1.3× 10 789
Christopher Plescia United States 4 175 0.6× 147 0.6× 188 1.2× 76 0.6× 100 1.0× 7 429
Kenia de los Santos-Alexis United States 6 147 0.5× 126 0.5× 116 0.7× 90 0.8× 107 1.0× 8 385
Candice R. Gurbatri United States 5 530 1.8× 442 1.7× 286 1.8× 200 1.7× 143 1.4× 7 901
Arthee Jahangir United States 8 235 0.8× 181 0.7× 174 1.1× 156 1.3× 309 3.0× 11 618
Mai T. Duong South Korea 7 399 1.4× 336 1.3× 125 0.8× 150 1.3× 59 0.6× 10 606
Panos Lehouritis Ireland 9 257 0.9× 181 0.7× 275 1.7× 171 1.4× 18 0.2× 9 549
Kelly Pu United States 4 242 0.8× 213 0.8× 132 0.8× 47 0.4× 36 0.3× 6 380

Countries citing papers authored by Fangda Li

Since Specialization
Citations

This map shows the geographic impact of Fangda Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangda Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangda Li more than expected).

Fields of papers citing papers by Fangda Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangda Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangda Li. The network helps show where Fangda Li may publish in the future.

Co-authorship network of co-authors of Fangda Li

This figure shows the co-authorship network connecting the top 25 collaborators of Fangda Li. A scholar is included among the top collaborators of Fangda Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangda Li. Fangda Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Wentao, Fangda Li, Yuehong Zheng, & Lei Wang. (2025). Myeloid Cells in Abdominal Aortic Aneurysm. Current Atherosclerosis Reports. 27(1). 57–57. 1 indexed citations
2.
Liu, Zhili, Liqiang Cui, Rong Zeng, et al.. (2025). Optimal timing of surgical treatment for Behcet’s disease aortic or peripheral artery pseudoaneurysms. Journal of Vascular Surgery. 82(2). 421–430.e3.
3.
Li, Fangda, Thomas Savage, Rosa L. Vincent, et al.. (2024). Programmable bacteria synergize with PD-1 blockade to overcome cancer cell–intrinsic immune resistance mechanisms. Science Immunology. 9(100). eadn9879–eadn9879. 13 indexed citations
4.
Im, Jongwon, Fangda Li, Mathieu Rouanne, et al.. (2024). Probiotic neoantigen delivery vectors for precision cancer immunotherapy. Nature. 635(8038). 453–461. 70 indexed citations breakdown →
7.
Vincent, Rosa L., et al.. (2024). Abstract 5237: Engineered probiotics direct the antigen specificity of CAR-T cells in situ. Cancer Research. 84(6_Supplement). 5237–5237. 2 indexed citations
8.
Decker-Farrell, Amanda R., Lukas Vlahos, H. Carlo Maurer, et al.. (2023). Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression. Cancer Discovery. 14(2). 348–361. 11 indexed citations
9.
Savage, Thomas, Rosa L. Vincent, Lei Huang, et al.. (2023). Chemokines expressed by engineered bacteria recruit and orchestrate antitumor immunity. Science Advances. 9(10). eadc9436–eadc9436. 96 indexed citations breakdown →
10.
Vincent, Rosa L., Candice R. Gurbatri, Fangda Li, et al.. (2023). Probiotic-guided CAR-T cells for solid tumor targeting. Science. 382(6667). 211–218. 146 indexed citations breakdown →
11.
Harimoto, Tetsuhiro, Jaeseung Hahn, Yuyu Chen, et al.. (2022). A programmable encapsulation system improves delivery of therapeutic bacteria in mice. Nature Biotechnology. 40(8). 1259–1269. 171 indexed citations breakdown →
12.
Li, Fangda, et al.. (2022). Deep Learning with Adaptive Attention for Seismic Velocity Inversion. Remote Sensing. 14(15). 3810–3810. 11 indexed citations
13.
Li, Fangda, et al.. (2022). Deep learning pre-stacked seismic velocity inversion using Res-Unet network. 171–174. 2 indexed citations
14.
Li, Fangda, Hongxia Wang, Yuan Li, et al.. (2021). Inhibition of CXCR2 alleviates the development of abdominal aortic aneurysm in Apo E-/- mice. Acta Cirúrgica Brasileira. 36(1). e360105–e360105. 5 indexed citations
15.
Li, Fangda, et al.. (2021). DEBISim: A simulation pipeline for dual energy CT-based baggage inspection systems. Journal of X-Ray Science and Technology. 29(2). 259–285. 9 indexed citations
16.
Li, Fangda, Wei Wang, Lei Ji, et al.. (2020). Macrophage pyroptosis is mediated by immunoproteasome subunit β5i (LMP7) in abdominal aortic aneurysm. Biochemical and Biophysical Research Communications. 533(4). 1012–1020. 15 indexed citations
17.
Li, Fangda, et al.. (2020). A Spectrum-Adaptive Decomposition Method for Effective Atomic Number Estimation Using Dual Energy CT. Electronic Imaging. 32(14). 293–1. 2 indexed citations
18.
Nie, Hao, Hongxia Wang, Cui Tian, et al.. (2018). Chemokine (C–X–C motif) receptor 2 blockade by SB265610 inhibited angiotensin II-induced abdominal aortic aneurysm in Apo E−/− mice. Heart and Vessels. 34(5). 875–882. 9 indexed citations
19.
Li, Fangda, et al.. (2018). RMPD — A Recursive Mid-Point Displacement Algorithm for Path Planning. Proceedings of the International Conference on Automated Planning and Scheduling. 28. 468–475. 1 indexed citations
20.
Wang, Wei, et al.. (2018). Surgical treatment for rare isolated left innominate vein aneurysms. Interactive Cardiovascular and Thoracic Surgery. 28(6). 989–991. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026